Clinical study on Yunnan white ointment in the treatment of fibromyalgia syndrome

首次发布于 2026 年 7 月 13 日

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

Recombinant anti-EGFR monoclonal antibody(Humanwell Healthcare (Group) Co., Ltd.)

Cetuximab biosimilar (Humanwell Healthcare)

KDC (Taiji Group Co. Ltd.)

Humanwell Healthcare (Group) Co., Ltd.

China

Tongji Healthcare Group Co., Ltd.

China

Yichang Humanwell Pharmaceutical Co., Ltd.

China

Comprehensive Clinical Trials Review Reveals Global Lennox-Gastaut Syndrome Research Landscape

Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease

AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results